§ BIOTECHNOLOGY
USD · BiotechnologyACLX
ARCELLX INC
USDSector · BiotechnologyBeta · 0.36
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX
§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY
13F FLOW
1 increased/new, 0 decreased/exited (13F)
AC 13F Analysis
§ 04 · FUNDAMENTALS · THE BOOKS
| P/B | 9.37 | EPS (TTM) | -4.06 |
§ 05 · WHO OWNS IT
Top institutional holders
| Fund | Shares | % port | Δ Q/Q |
|---|---|---|---|
| GILEAD SCIENCES, INC. | 6.7M | 36.4% | ±0% |
| Paradigm Biocapital Advisors LP | 5.8M | 13.5% | +1% |
| BlackRock | 3.9M | 0.0% | +11% |
| NEA Management Company, LLC | 3.0M | 19.9% | ±0% |
| Pentwater Capital Management LP | 2.9M | 1.7% | n/a |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.4M | n/a | n/a |
◇ AC INTELLIGENCE
Top institutional owners for ACLX as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.
§ 06 · WHO OWNS IT · BY STRATEGY
OTHER99.1% · 0 holders
OTHER0.6% · 167 holders
DEALER / BANK0.1% · 28 holders
PASSIVE / INDEX0.1% · 9 holders
QUALITY / COMPOUNDER0.1% · 11 holders
TACTICAL / MACRO0.0% · 6 holders
INCOME / DEFENSIVE0.0% · 13 holders
SYSTEMATIC / QUANT0.0% · 7 holders
GROWTH / MOMENTUM0.0% · 1 holder
◇ AC INTELLIGENCE
Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.
§ 07 · INSIDER ACTIVITY · LAST 180 DAYS
NO INSIDER FILINGS
◇ AC INTELLIGENCE
No Form 4 filings on record for ACLX in the last 180 days.
§ 08 · COVERAGE · OUR RECENT NOTES
No notes mention ACLX yet.